Edwards Lifesciences Corp - COM (EW)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
471M
Holdings value Q3 2024
$31.1B
Value change Q3 2024
-$2.05B
Grand Portfolio weight change Q3 2024
-0.004%
Number of holders
1151
Number of buys Q3 2024
473
Number of sells Q3 2024
-711
Average buys Q3 2024 %
+0.007%
Average sells Q3 2024 %
-0.009%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 471M $31.1B -$2.05B $65.99 1,158
2024 Q2 491M $45.4B +$1.46B $92.37 1,268
2024 Q1 477M $45.5B +$279M $95.56 1,244
2023 Q4 475M $36.2B -$333M $76.25 1,222
2023 Q3 481M $33.3B -$1.1B $69.28 1,192
2023 Q2 492M $46.3B -$216M $94.33 1,253
2023 Q1 494M $40.9B -$932M $82.73 1,216
2022 Q4 504M $37.6B -$103M $74.61 1,194
2022 Q3 505M $41.8B -$218M $82.63 1,213
2022 Q2 507M $48.2B +$341M $95.09 1,243
2022 Q1 506M $59.5B -$872M $117.72 1,289
2021 Q4 513M $66.4B -$183M $129.55 1,295
2021 Q3 511M $57.9B +$237M $113.21 1,207
2021 Q2 509M $52.8B +$536M $103.57 1,166
2021 Q1 506M $42.3B -$426M $83.64 1,115
2020 Q4 514M $46.8B +$9.04M $91.23 1,137
2020 Q3 514M $41B +$886M $79.82 1,071
2020 Q2 503M $34.8B +$22.8B $69.11 1,019
2020 Q1 169M $31.8B -$671M $188.62 987
2019 Q4 172M $40B +$48.9M $233.29 1,070
2019 Q3 172M $37.7B -$178M $219.91 952
2019 Q2 173M $31.9B +$288M $184.74 909
2019 Q1 175M $33.5B -$302M $191.33 919
2018 Q4 177M $27.1B +$79.1M $153.17 865
2018 Q3 175M $30.5B +$111M $174.10 848
2018 Q2 175M $25.5B +$115M $145.57 829
2018 Q1 174M $24.3B +$51.5M $139.52 806
2017 Q4 174M $19.6B -$380M $112.71 770
2017 Q3 177M $19.3B +$149M $109.31 734
2017 Q2 176M $20.8B +$124M $118.24 716
2017 Q1 176M $16.6B +$753M $94.07 682
2016 Q4 178M $16.7B -$154M $93.70 673
2016 Q3 180M $21.6B +$143M $120.56 686
2016 Q2 179M $17.9B -$104M $99.73 682
2016 Q1 178M $15.7B -$195M $88.21 643
2015 Q4 183M $14.4B +$7.51B $78.98 594
2015 Q3 87.9M $12.5B +$390M $142.17 560
2015 Q2 85.1M $12.1B -$844M $142.43 573
2015 Q1 90.8M $12.9B -$27.6M $142.46 567
2014 Q4 91.8M $11.7B -$62.4M $127.38 553
2014 Q3 92.1M $9.4B -$118M $102.15 483
2014 Q2 93.3M $8.01B -$353M $85.84 423
2014 Q1 97.6M $7.24B -$51.8M $74.17 402